英文别名:
Dexamethasone valerate;9-Fluoro-11b,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione 17-valerate;9-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-valerate;Betamethason-17-valerat;Betamethason-17-valerianat;Betamethazon-17-valerat;Dexamethasone-17-valerate;DV 17;DXMvalerate;Voalla;Zalucs;Betamethasone Valerate Impurity C;EINECS 251-669-2;CHEBI:135770;Tox21_111565;BETAMETHASONE VALERATE IMPURITY C [EP IMPURITY];[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] pentanoate;PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,21-DIHYDROXY-16-METHYL-17-((1-OXOPENTYL)OXY)-, (11.BETA.,16.ALPHA.)-;Dexamethasone 17-valerate;Dexamethasone valerate [JAN];Q27285667;CHEMBL1378167;DV-17;DTXCID602904;UNII-OI7CP949NN;Tox21_111565_1;Dexamethasone Valarate;AKOS032429285;DTXSID3022904;SCHEMBL124723;NCGC00274064-01;Dexamethasone valerate (JAN);NS00089615;DEXAMETHASONE VALERATE [WHO-DD];NCGC00159316-02;D01948;Voalla ointment (TN);33755-46-3;Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-alpha-methyl-, 17-valerate;OI7CP949NN;CAS-33755-46-3;DEXAMETHASONE-17 VALERATE;
Inchi:
1S/C27H37FO6/c1-5-6-7-23(33)34-27(22(32)15-29)16(2)12-20-19-9-8-17-13-18(30)10-11-24(17,3)26(19,28)21(31)14-25(20,27)4/h10-11,13,16,19-21,29,31H,5-9,12,14-15H2,1-4H3/t16-,19+,20+,21+,24+,25+,26+,27+/m1/s1